ReviewZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024
[Recurrent arterial thrombosis during extracorporeal membrane oxygenation: a case report and literature review].
Review in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extracorporeal membrane oxygenation (ECMO) is an advanced technology that provides short-term life support for patients with severe cardiopulmonary failure based on the principle of cardiopulmonary bypass. However, various complications such as acute limb ischemia, osteofascial compartment syndrome, hemorrhage and thrombosis can also occur. A retrospective analysis was performed on a 58-year-old Han male patient with acute myocardial infarction complicated with cardiogenic shock in our department. After the conventional treatment failed, he received urgent VA-ECMO treatment. During this period, arterial thrombosis occurred repeatedly, improved after anticoagulant and antithrombotic treatment, and finally died due to infection. Acute limb ischemia caused by arteriovenous thrombosis is one of the possible serious complications during ECMO treatment. Prevention of thrombosis and optimization of anticoagulant and antithrombotic regimen are the main therapeutic measures. Anticoagulation is still the main treatment method for venous thrombosis during ECMO treatment. Anti-thrombotic drugs are not routinely given during ECMO, while anti-thrombotic drugs are the primary treatment for high-risk arterial thrombosis risk patients. Therefore, early detection of complications and timely intervention are crucial. Early intervention or surgical operation can reduce the incidence of ischemia,improve the survival rate and reduce the disabling outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.